Management of Non-Hodgkin's Lymphoma Relapse
Abstract
Evidence is reviewed that supports an approach to managing patients who have relapsed or never achieved a remission after front-line chemotherapy for aggressive lymphoma. Also discussed is how intensive therapy and autotransplant can be used in an evidence-based manner to provide the best outcome for these patients.
|
Management of Non-Hodgkin's Lymphoma Relapse
|
Help
Viewing Private Lectures requires Quicktime
4 
Check here to
determine if QuickTime is properly installed on your computer.
 Copyright 1995-2010 - Carden Jennings Publishing Co., Ltd. All rights reserved. The material available at this site is for educational purposes only and is NOT intended for any diagnostic, clinically related, or other purpose. Carden Jennings Publishing Co., Ltd., assumes no responsibility for any use or misuse of this material and makes no warranty or representation of any kind with respect to the material available at this site.
|
|
![[BLlogo7.gif]](http://mmserver.cjp.com/images/blood/BLlogo7.gif)
